Ekström, Claes
Ortenlöf, Niklas
Kristiansson, Amanda
Holmqvist, Bo
Jungner, Åsa
Vallius, Suvi
Wang, Xiaoyang
Hellström, Ann
Barton, Norman
Carey, Galen
Ley, David
Gram, Magnus
Funding for this research was provided by:
Vetenskapsrådet (2020-01235)
Takeda Pharmaceuticals U.S.A.
Governmental ALF research grants
Crafoordska Stiftelsen
Alfred Österlunds Foundation
Lund University
Article History
Received: 24 April 2023
Accepted: 2 November 2023
First Online: 13 November 2023
Change Date: 24 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-024-60175-7
Competing interests
: The authors declare the following potential conflicts of interest concerning the research, authorship, and/or publication of this article: C.G. is an employee and shareholder in Takeda Pharmaceutical Company Ltd and N.B. was employed by Takeda Pharmaceutical Company Ltd. and is a shareholder of Takeda Pharmaceutical Company Ltd. D.L. and A.H. hold stock/stock options in Premalux AB and has received consulting fees from Shire PLC. All other authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.